Da
En
Fr
De
Sv
Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software & TMT
Research
Equity Research
Macro and markets
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
Da
En
Fr
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
News
Alle
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
04 okt 2024
Equity research, Zinzino: On track to achieve growth target
Equity Research
Zinzino
02 okt 2024
Carlsquare weekly market letter: China took the lead – what’s next?
Equity Research
Carlsquare
25 sep 2024
Carlsquare weekly market letter: Is China finally taking off?
Equity Research
Carlsquare
23 sep 2024
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
18 sep 2024
Carlsquare weekly market letter: Another leg down – or time for small caps?
Equity Research
Carlsquare
16 sep 2024
Carlsquare Equity Research: Swedish consumer sector snapshot
Equity Research
Viva Wine Group
12 sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Equity Research
Biosergen
11 sep 2024
Carlsquare weekly market letter: How to deal with a stormy market
Equity Research
Carlsquare
09 sep 2024
Equity Research Svenska Aerogel, Q2 2024: Low revenues, but important orders in place
Equity Research
Svenska Aerogel
05 sep 2024
Equity research Zinzino: Making a late summer splash
Equity Research
Zinzino
04 sep 2024
Carlsquare weekly market letter: Time for a new bump in the road?
Equity Research
Carlsquare
03 sep 2024
Equity Research Enrad Q2 2024: Enrad should invest in growing markets
Equity Research
Enrad
02 sep 2024
Equity research Zinzino: Robust profit growth despite lower gross margin in Q2 2024
Equity Research
Zinzino
30 aug 2024
Equity research Enrad, Q2 2024: Very strong quarter
Equity Research
Enrad
30 aug 2024
Equity research Zinzino: Profit growth despite pressure on gross margin in Q2 2024
Equity Research
Zinzino
29 aug 2024
Equity Research Svenska Aerogel, Q2 2024: Net revenues below expectations, but better profitability
Equity Research
Svenska Aerogel
29 aug 2024
Equity research Viva Wine Group: Profitability uptick ahead of expectations
Equity Research
Viva Wine Group
29 aug 2024
Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow
Equity Research
Nosa Plugs
28 aug 2024
Equity research Viva Wine Group: Return to strong EBITA growth in Q2 2024
Equity Research
Viva Wine Group
28 aug 2024
Carlsquare weekly market letter: Does the Fed know something we don't?
Equity Research
Carlsquare
1
2
3
…
53